Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Invent Medic Sweden

0.21 SEK

+2.40 %

Less than 1K followers

IMS

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+2.40 %
+15.76 %
+34.81 %
+40.13 %
+5.45 %
+33.13 %
-72.08 %
-96.63 %
-92.27 %

Invent Medic Sweden is active in women's health. The company owns the brands Efemia and FlowCup. The Efemia brand is sold through the healthcare sector and includes the product Efemia Bladder Support, a CE-marked and patented medical device for stress incontinence. FlowCup's product portfolio contains menstrual-related products and is aimed at consumers via its own e-commerce channel. The company was founded in 2005 and has its headquarters in Lund.

Read more
Market cap
23.55M SEK
Turnover
11.01K SEK
Revenue
7.35M
EBIT %
-84.63 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
13/2
2026

Annual report '25

5/5
2026

Interim report Q1'26

5/5
2026

General meeting '26

All
Press releases
ShowingAll content types
Regulatory press release10/24/2025, 7:00 AM

Invent Medic Sweden: Invent Medic publicerar kvartalsrapport för kvartal 3 2025

Invent Medic Sweden
Press release10/21/2025, 11:43 AM

Invent Medic Sweden: Invent Medic bjuder in till digital genomgång av Q3-rapporten - ny länk!

Invent Medic Sweden
Press release10/16/2025, 6:11 AM

Invent Medic Sweden: Invent Medic bjuder in till digital genomgång av Q3-rapporten

Invent Medic Sweden

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release10/14/2025, 12:12 PM

Invent Medic Sweden: Intervju med vår VD Gunilla Nilsson om Invent Medics utveckling och ökade marknadsmomentum

Invent Medic Sweden
Press release10/14/2025, 9:55 AM

Analyst Group: Analyst Group intervjuar Invent Medics VD Gunilla Nilsson

Invent Medic Sweden
Press release9/22/2025, 7:00 AM

Invent Medic Sweden: Invent Medic klarar inspektioner av Efemia Bladder Support och kvalitetssystem - helt utan avvikelser

Invent Medic Sweden
Press release9/19/2025, 1:50 PM

Invent Medic Sweden: Invent Medic får rekordorder via iMEDicare i Storbritannien

Invent Medic Sweden
Press release9/10/2025, 7:28 AM

Invent Medic Sweden: Invent Medic tecknar distributionsavtal med Cliniqon Biotech för lansering i Sri Lanka

Invent Medic Sweden
Press release9/2/2025, 2:10 PM

Invent Medic Sweden: Invent Medic stärker säljteamet för Efemia i Sverige

Invent Medic Sweden
Press release8/26/2025, 1:38 PM

Invent Medic Sweden: Första ordern från Welthungerhilfe när Invent Medic växlar upp samarbeten med NGOs

Invent Medic Sweden
Regulatory press release8/15/2025, 6:59 AM

Invent Medic Sweden: Invent Medic publicerar kvartalsrapport för kvartal 2 2025

Invent Medic Sweden
Regulatory press release5/5/2025, 1:49 PM

Kommuniké från årsstämma i Invent Medic Sweden AB (publ)

Invent Medic Sweden
Regulatory press release5/5/2025, 10:46 AM

Invent Medic Sweden: Invent Medic publicerar kvartalsrapport för kvartal 1 2025

Invent Medic Sweden
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.